Recombinant multi-species MGP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MGP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the osteocalcin/matrix Gla family of proteins. The encoded vitamin K-dependent protein is secreted by chondrocytes and vascular smooth muscle cells, and functions as a physiological inhibitor of ectopic tissue calcification. Carboxylation status of the encoded protein is associated with calcification of the vasculature in human patients with cardiovascular disease and calcification of the synovial membranes in osteoarthritis patients. Mutations in this gene cause Keutel syndrome in human patients, which is characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and facial hypoplasia. [provided by RefSeq, Sep 2016]
The Alternative Names of target: Cell growth-inhibiting gene 36 protein,GIG36,MGLAP,MGP,Matrix Gla protein,Mglap,Mgp,NTI
Go
to MGP products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1099-Ag-1/ GM-Tg-hg-SE1099-Ag-2 | Human MGP protein | Human |
| GM-Tg-rg-SE1099-Ag-1/ GM-Tg-rg-SE1099-Ag-2 | Rat MGP protein | Rat |
| GM-Tg-mg-SE1099-Ag-1/ GM-Tg-mg-SE1099-Ag-2 | Mouse MGP protein | Mouse |
| GM-Tg-cynog-SE1099-Ag-1/ GM-Tg-cynog-SE1099-Ag-2 | Cynomolgus/Rhesus macaque MGP protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1099-Ag-1/ GM-Tg-felg-SE1099-Ag-2 | Feline MGP protein | Feline |
| GM-Tg-cang-SE1099-Ag-1/ GM-Tg-cang-SE1099-Ag-2 | Canine MGP protein | Canine |
| GM-Tg-bovg-SE1099-Ag-1/ GM-Tg-bovg-SE1099-Ag-2 | Bovine MGP protein | Bovine |
| GM-Tg-equg-SE1099-Ag-1/ GM-Tg-equg-SE1099-Ag-2 | Equine MGP protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1099-Ag-1/ GM-Tg-hg-SE1099-Ag-2;
GM-Tg-rg-SE1099-Ag-1/ GM-Tg-rg-SE1099-Ag-2;
GM-Tg-mg-SE1099-Ag-1/ GM-Tg-mg-SE1099-Ag-2; GM-Tg-cynog-SE1099-Ag-1/ GM-Tg-cynog-SE1099-Ag-2; GM-Tg-felg-SE1099-Ag-1/ GM-Tg-felg-SE1099-Ag-2; GM-Tg-cang-SE1099-Ag-1/ GM-Tg-cang-SE1099-Ag-2; GM-Tg-bovg-SE1099-Ag-1/ GM-Tg-bovg-SE1099-Ag-2; GM-Tg-equg-SE1099-Ag-1/ GM-Tg-equg-SE1099-Ag-2 |
| Products Name | MGP protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MGP |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MGP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.